Label: SENNA LAXATIVE- sennosides 8.6 mg tablet
- NDC Code(s): 84324-012-01
- Packager: NUVICARE LLC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated July 17, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active Ingredient
- Purpose
- Uses:
- Warnings:
- ASK DOCTOR
- STOP USE
- PREGNANCY OR BREAST FEEDING
- KEEP OUT OF REACH OF CHILDREN
-
DIRECTIONS
- Take preferably at bedtime or as directed by a doctor.
age
starting dosage
maximum dosage
adults & children 12 years of age and over
2 tablets once a day
4 tablets twice a day
children 6 to under 12 years
1 tablet once a day
2 tablets twice a day
children 2 to under 6 years
1 /2 tablet once a day
1 tablet twice a day
children under 2 years
ask a doctor
ask a doctor
- OTHER INFORMATION
- INACTIVE INGREDIENTS
- QUESTIONS OR COMMENTS?
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
SENNA LAXATIVE
sennosides 8.6 mg tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:84324-012 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES 8.6 mg Inactive Ingredients Ingredient Name Strength SODIUM LAURYL SULFATE (UNII: 368GB5141J) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) STEARIC ACID D7 (UNII: T3B081197X) PARAFFIN (UNII: I9O0E3H2ZE) DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP) HYPROMELLOSES (UNII: 3NXW29V3WO) MAGNESIUM STEARATE (UNII: 70097M6I30) MALTODEXTRIN (UNII: 7CVR7L4A2D) CROSCARMELLOSE SODIUM (UNII: M28OL1HH48) Product Characteristics Color brown Score no score Shape ROUND Size 10mm Flavor Imprint Code none Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:84324-012-01 200 in 1 BOTTLE; Type 0: Not a Combination Product 07/17/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug 505G(a)(3) 07/17/2024 Labeler - NUVICARE LLC (119257565) Registrant - NUVICARE LLC (119257565)